Cargando…
Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies
Fluoroquinolones, a class of compound, act via inhibiting DNA gyrase and topoisomerase IV enzymes. This is an important class of drugs with high success rates for the treatment of tuberculosis and other bacterial infections. An indirect drug design approach was used to develop a meaningful pharmacop...
Autores principales: | Mathpal, Deepti, Masand, Mukesh, Thomas, Anisha, Ahmad, Irfan, Saeed, Mohd, Zaman, Gaffar Sarwar, Kamal, Mehnaz, Jawaid, Talha, Sharma, Pramod K., Gupta, Madan M., Kumar, Santosh, Srivastava, Swayam Prakash, Balaramnavar, Vishal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042709/ https://www.ncbi.nlm.nih.gov/pubmed/35494744 http://dx.doi.org/10.1039/d1ra05630a |
Ejemplares similares
-
Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M(pro)
por: Balaramnavar, Vishal M., et al.
Publicado: (2020) -
Identification of 3-((1-(Benzyl(2-hydroxy-2-phenylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrazine-2-carboxylic Acid as a Potential Inhibitor of Non-Nucleosidase Reverse Transcriptase Inhibitors through InSilico Ligand- and Structure-Based Approaches
por: Mathpal, Deepti, et al.
Publicado: (2021) -
Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M(pro)
por: Balaramnavar, Vishal M., et al.
Publicado: (2020) -
Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores
por: Tomašič, Tihomir, et al.
Publicado: (2021) -
PharmDock: a pharmacophore-based docking program
por: Hu, Bingjie, et al.
Publicado: (2014)